Medical Pharmacology: Antiviral Drug Practice Questions
Click on the correct answer.
Tenofovir disoproxil fumerate (TDF, Viread): a nucleotide reverse transcriptase inhibitor
True
False
Tenofovir is a prodrug:
Available as the disoproxil formulation
Available as the alafenamide formulation
Both
Neither
Tenofovir exhibits antiviral activity with respect to which one(s) of the following?
HIV-1
HSV-2
HBV (Hepatitis B Virus)
A & B
B & C
A & C
A, B & C
Tenofovir disoproxil fumarate (TDF):
FDA approved for treating HIV in adults.
FDA approved for treating HIV in children >2 years old.
Used in combination with other antiretrovirals.
A & B
B & C
A & C
A, B & C
Tenofovir disoproxil fumarate (TDF): when administered in combination with emtricitabine (Emtriva) the combination may be used for "HIV preexposure prophylaxis."
True
False
Tenofovir alafenamide (TAF), in addition to treating HIV and HBV, this agent in combination with emtricitabine may be used for HIV prophylaxis.
True
False
Tenofovir disoproxila fumerate (Viread):
Water-soluble prodrug
Oral bioavailability: about 25% (fasting) to about 40% following a meal high in fat.
If you wish to return to the Table of Contents
in ENGLISH, press the RETURN button above.
Otherwise, if the text is NOT displayed in
English and you are ready to leave this page,
Press here
to return to the Table of Contents
Source Material:
Acosta EP Chapter 62 Antiviral Agents (Nonretroviral)
in Goodman & Gilman's: The Pharmcological
Basis of Therapeutics, 14e, (Brunton LL Knollmann BC eds) McGraw-Hill Education, 2023.
Safrin S Chapter 49 Antiviral Agents in
Basic & Clinical Pharmacology (Katzung BG, Editor;
Vanderah TW, Associate editor) 15e McGraw Hill 2021.
Li JZ Coen DM Chapter 38 Pharmacology of
Viral Infections in Principles of Pharmacology:
The Pathophysiologic Basis of Drug Therapy 4e (Golan DE
Armstong EJ Armstrong AW, eds) Wolters Kluwer 2017.
Waller DB Sampson AP Section 11
Chemotherapy in Medical Pharmacology & Therapeutics
Elsevier 2018.
Burchum JR Rosenthal LD Chapter 97
Antiviral Agents I: Drugs for Non-HIV Viral Infections
in Lehne's Pharmacology for Nursing Care Elsevier 2022.
Waller DB Sampson AP Section 11: Chapter
51
Chemotherapy of infections in Medical Pharmacology & Therapeutics
Elsevier 2018.
Benavides S Bahal O'Mara N Nahata MC
Chapter 79 Viral Infections in Applied Therapeutics:
The Clinical Use of Drugs (Zeind C, Carvalho MG Cheng JW
Zaiken K Lapointe T, eds) Wolters Kluwer, 2024.
Davanathan AS Symonds AE Adams JL
Cottrell ML Chapter 76 Pharmacotherapy of Human
Immunodeficiency Virus Infection
in Applied
Therapeutics: The Clinical Use of Drugs (Zeind C, Carvalho MG Cheng JW
Zaiken K Lapointe T, eds) Wolters Kluwer, 2024.
Flexner CW Chapter 64 Antiretroviral
Agents and Treatment of HIV Infection
in Goodman &
Gilman's: The Pharmcological
Basis of Therapeutics, 14e, (Brunton LL Knollmann BC eds) McGraw-Hill Education, 2023.
Burchum JR Rosenthal LD Chapter
98
Antiviral Agents II: Drugs for HIV Infection and Related
Opportunistic Infections
in Lehne's Pharmacology for Nursing Care Elsevier 2022.